OmniAb (OABI) EBT Margin (2022 - 2026)

OmniAb's (OABI) quarterly EBT Margin came in at 50.36% in Q1 2026, up 39033.0% year-on-year from N/an in Q1 2025, and up 71.0% on a QoQ basis from 173.66% in Q4 2025.

OmniAb (OABI) EBT Margin (2022 - 2026) Analysis & Trends

OmniAb (OABI) has 5 years of EBT Margin data on file, last reported at 50.36% in Q1 2026.

  • On a quarterly basis, EBT Margin rose 39033.0% year-over-year to 50.36% in Q1 2026; TTM through Mar 2026 was 190.93%, a 6385.0% increase from a year earlier, with the FY2025 full-year figure at 355.16%, down 8457.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 50.36%, up from 173.66% in the prior quarter.
  • Over the last five years, EBT Margin for OABI reached as high as 27.27% in Q4 2022 and fell as low as 789.91% in Q3 2025.
  • Historically, EBT Margin has averaged 279.06% across 5 years, with a median of 215.76% in 2022.
  • Across the five-year window, EBT Margin plunged 52556 bps in 2024 and soared 39033 bps in 2026, its largest moves.
  • Year by year, EBT Margin stood at 27.27% in 2022, then slumped by 1623 bps to 415.35% in 2023, then jumped by 66 bps to 140.9% in 2024, then retreated by 23 bps to 173.66% in 2025, then jumped by 71 bps to 50.36% in 2026.
  • Per Business Quant data, the three most recent EBT Margin figures were 50.36% in Q1 2026, 173.66% in Q4 2025, and 789.91% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 OmniAb 261.62 Mn 212.55 Mn 14.41 Mn -50.36%

Historic Data

Download Data
DateValue
Mar 31, 2026 -50.36%
Dec 31, 2025 -173.66%
Sep 30, 2025 -789.91%
Jun 30, 2025 -404.31%
Mar 31, 2025 -440.68%
Dec 31, 2024 -140.90%
Sep 30, 2024 -457.36%
Jun 30, 2024 -203.95%
Mar 31, 2024 -567.69%
Dec 31, 2023 -415.35%
Sep 30, 2023 -347.67%
Jun 30, 2023 -261.50%
Mar 31, 2023 -42.14%
Dec 31, 2022 27.27%
Sep 30, 2022 -215.76%
Jun 30, 2022 -174.55%
Mar 31, 2022 -85.45%